Recall Record

Princeton, NJ, United States

Geistlich Pharma North America, Inc. recalls

2 recalls recorded since 2018, most recently on 19 October 2020. None are listed as ongoing. Status and classification are as published by the FDA.

Recalls2
Ongoing (FDA)0
Terminated or completed2
Class I (FDA)0

Terminated Class II Medical devices

Recall started
19 October 2020
Terminated
13 July 2021
Reason
Difficult to expel Geistlich Bio-Oss granules from the pen, resistance could suddenly drop, and the granules may be expelled all at once, causing surrounding tissue, particularly in use for the sinus lift indication and while unlikely, could pose a risk for patient harm, including irritation of the oral mucosa or even a perforation of the Schneiderian membrane
Distribution
Worldwide distribution - US Nationwide distribution and the country of Japan.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-0492-2021, Z-0491-2021, Z-0490-2021

Terminated Class II Medical devices

Recall started
12 April 2019
Terminated
21 October 2020
Reason
When unscrewing the green cap from the pen, a visible piece of green plastic was seen on the outer barrel of the pen.
Distribution
US Nationwide distribution.
Initiated
Voluntary: Firm initiated
Recall numbers
Z-2147-2019, Z-2145-2019, Z-2146-2019

A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.